Artivion | CRY - Kısa Vadeli Yükümlülükler





Kısa Vadeli Yükümlülükler Değişiklik Tarih
Abbott USD 16.15B 1.66B 2026-09
Accuray USD 199.44M 4.83M 2025-12
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 76.66M 30.28M 2026-09
AtriCure USD 83.97M 2.06M 2026-09
Baxter International USD 3.81B 218M 2026-09
Becton, Dickinson and Co. USD 9.54B 139M 2026-09
Boston Scientific USD 5.98B 446M 2026-09
Edwards Lifesciences USD 1.58B 68.8M 2026-09
Inogen USD 64.94M 2.12M 2025-09
Integra LifeSciences USD 329M 1.88M 2026-09
J&J USD 55.46B 562M 2026-09
Mesa Laboratories USD 54.4M 6.1M 2025-12
Orthofix International USD 138.38M 18.62M 2026-09
Pfizer USD 31.73B 920M 2026-09
ResMed USD 1.32B 70.89M 2026-09
Stryker USD 6.5B 184M 2026-09
Tandem Diabetes Care USD 256.08M 3.07M 2026-09
Teleflex USD 917.1M 196.72M 2026-09
Terumo JPY 306.08B 107.19B 2026-09
Trinity Biotech USD 143.68M 2.48M 2026-03